Post-Term Pregnancy
Clinical trial pipeline · Data from ClinicalTrials.gov
See which Post-Term Pregnancy trials you may qualify forClinical trial pipeline · Data from ClinicalTrials.gov
See which Post-Term Pregnancy trials you may qualify forThe objective of this post market, clinical registry is to evaluate the performance of the products of the TVT family of products or vaginal vault or uterine pr…
This phase III trial compares the effect of adding tivozanib to standard therapy pembrolizumab versus pembrolizumab alone for the treatment of patients with hig…
The objective of this single arm, post market, clinical study is to evaluate the performance of Gynecare TVT ABBREVO® Continence System in women undergoing Mid-…
The participants of this study will be of any age who are exposed to at least 1 dose of odevixibat at any time during pregnancy (from 1 day prior to conception…
Preimplantation genetic testing (PGT) is a reproductive genetic technique aimed at preventing the transmission of severe genetic disorders. In France, its use i…
The purpose of this study is to determine if non-steroidal anti-inflammatory (NSAID) use in the postoperative setting increases the risk of acute kidney injury…
The objective of this single arm, post market, clinical study is to evaluate the performance of Gynecare TVT EXACT® Continence System in women undergoing retrop…
The study will include participants who were exposed to at least one dose of elafibranor either within the three weeks before conception or at any time during p…
15 to 20 % of nulliparous needs an induction at term. None study has evaluated Foley catheter induction at home versus expectative in this population